Nuzenio

India Dementia

India Dementia news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

country 14 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Rutgers Launches First US Study On Alzheimer’s Risk In South Asian Americans - IndiaWestIndiaWest · Fri, 07 Aug 2026 13:59:48 GMT Leqembi for early Alzheimer's treatment launched in India after CDSCO nod - The HinduThe Hindu · Wed, 05 Aug 2026 10:29:33 GMT Eisai Launches Leqembi in India for Early Alzheimer’s Disease - NAVLIN DAILYNAVLIN DAILY · Tue, 04 Aug 2026 08:03:14 GMT Eisai launches Alzheimer's drug Leqembi in India after CDSCO approval - Business StandardBusiness Standard · Tue, 04 Aug 2026 06:19:52 GMT Eisai launches LEQEMBI, India's first disease-modifying therapy for early Alzheimer's disease - Indian Pharma PostIndian Pharma Post · Mon, 03 Aug 2026 14:21:43 GMT Eisai launches LEQEMBI for early Alzheimer’s disease treatment in India - Telangana TodayTelangana Today · Mon, 03 Aug 2026 12:30:52 GMT Japanese drugmaker Eisai bets on early Alzheimer’s care with Leqemb's India launch - Moneycontrol.comMoneycontrol.com · Mon, 03 Aug 2026 12:08:11 GMT Eisai launches first-of-its-kind disease-modifying therapy for early Alzheimer’s Disease in India - biospectrumindia.combiospectrumindia.com · Mon, 03 Aug 2026 11:42:19 GMT

Timeline

Fri, 07 Aug 2026 13:59:48 GMTRutgers Launches First US Study On Alzheimer’s Risk In South Asian Americans - IndiaWest

Wed, 05 Aug 2026 10:29:33 GMTLeqembi for early Alzheimer's treatment launched in India after CDSCO nod - The Hindu

Tue, 04 Aug 2026 08:03:14 GMTEisai Launches Leqembi in India for Early Alzheimer’s Disease - NAVLIN DAILY

Tue, 04 Aug 2026 06:19:52 GMTEisai launches Alzheimer's drug Leqembi in India after CDSCO approval - Business Standard

Mon, 03 Aug 2026 14:21:43 GMTEisai launches LEQEMBI, India's first disease-modifying therapy for early Alzheimer's disease - Indian Pharma Post

Mon, 03 Aug 2026 12:30:52 GMTEisai launches LEQEMBI for early Alzheimer’s disease treatment in India - Telangana Today

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Alzheimer17 live mentions India17 live mentions Eisai9 live mentions LEQEMBI6 live mentions Disease5 live mentions CDSCO4 live mentions Leqembi3 live mentions Indian Pharma Post3 live mentions Moneycontrol3 live mentions Risk In South2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for India Dementia.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.